Elevation Oncology
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -5 | -4 | -10 | |
EBITDA | -6,376 | -13,224 | -10,959 | -9,859 |
EBIT | -6,381 | -13,229 | -10,963 | -9,869 |
Net Income | -10,436 | -12,881 | -10,461 | -10,707 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,202 | -8,382 | -8,205 | -9,575 |
Cash | 49,464 | 48,202 | 59,447 | 90,630 |
Basic Shares | 59,122 | 59,108 | 59,018 | 47,371 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -39 | -27 | -18 | |
EBITDA | -44,703 | -41,467 | -94,522 | -32,028 |
EBIT | -43,239 | -41,506 | -94,549 | -32,046 |
Net Income | -44,485 | -45,704 | -95,080 | -32,039 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -100,367 | |||
Free Cash Flow | -36,364 | -56,180 | -85,569 | -30,167 |
Cash | 49,464 | 49,255 | 45,917 | 146,284 |
Basic Shares | 57,275 | 34,077 | 23,267 | 23,205 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.18 |
2024-09-30 | -$0.22 |
2024-06-30 | -$0.18 |
2024-03-31 | -$0.23 |
